Biomarkers of Aging
2025 Conference

HARVARD

Vadim Gladyshev is a professor of medicine at Brigham and Women's Hospital and Harvard Medical School. Vadim Gladyshev's primary research focuses on understanding the mechanisms behind aging, lifespan control, and rejuvenation.

Dr. Gladyshev is the recipient of NIH Pioneer, Transformative and Eureka awards and is an elected member of the National Academy of Sciences, USA.

HARVARD

Mahdi Moqri is an Instructor in Aging Research at Harvard (Gladyshev Lab, Genetics) and Stanford (Snyder Lab, Genetics), and leading the executive committee of the Biomarkers of Aging Consortium.

HARVARD

Jesse Poganik is an Instructor in Medicine at Brigham and Women’s Hospital and Harvard Medical School. His research focuses on understanding the fundamental aspects of aging: the temporal dynamics of biological age, the inter-cellular and inter-tissue dynamics of aging. Jesse Poganik also serves on the Executive Committee of the Biomarkers of Aging Consortium.

NATIONAL UNIVERSITY OF SINGAPORE
CHI LONGEVITY FOUNDER

Dr. Maier is a Professor in Medicine and Healthy Ageing and the Co-Director of Center for Healthy Longevity at the National University of Singapore and a Fellow of the Royal Australasian College of Physicians.

AARP CHAIR IN GERONTOLOGY
USC DAVIS SCHOOL OF GERONTOLOGY

Eileen Crimmins is the AARP Professor in the Davis School of Gerontology at the University of Southern California. Her research focuses on using biomarkers to explain population differences in aging health. She co directs an NIH sponsored Biomarker Network.

RWT AACHEN MEDICAL SCHOOL

Dr. Wagner is chair of the Institute for Stem Cell Biology at the Medical Faculty of RWTH Aachen University in Germany and co-founder of Cygenia GmbH, which provides services in the field of epigenetic analysis. His research focuses on DNA methylation changes during differentiation and, in particular, during the aging process, with the aim of gaining a better understanding of what drives epigenetic clocks and how they are coordinated.

Tommy Kaplan is a Professor of Computer Science and Computational Biology at Hebrew University. His research focuses on biology of aging, genomics, DNA methylation, Machine Learning and cell-free DNA.

DUKE UNIVERSITY

Terrie Moffitt is the Nannerl O. Keohane University Professor of Psychology at Duke University, and Professor of Social Development at King’s College London. She is the PI of the team who developed DunedinPACE and is Associate Director of the Dunedin Longitudinal Study, which follows a 1972 birth cohort in New Zealand. In her spare time, she works on her poison-ivy farm in North Carolina.

UNIVERSITY OF TORONTO

Dr. Wang, Chief Artificial Intelligence Scientist at the University Health Network and Canada CIFAR AI Chair at the Vector Institute, conducts research at the intersection of machine learning and computational biology.

BROAD INSTITUTE

Fei Chen, a core member of the Broad Institute and associate professor at Harvard, develops innovative tools integrating single-cell genomics with spatial and temporal analysis to uncover how and when cell types function within intact tissues.

BUCK INSTITUTE

Nathan D. Price is a systems biologist and bioengineer specializing in the use of systems biology and AI to advance human health, aging, and scientific wellness, and serves as co-director of the Center for Human Healthspan at the Buck Institute and affiliate faculty at the University of Washington.

NORTHEASTERN UNIVERSITY

Albert-László Barabási, is Distinguished Professor at Northeastern University and faculty at the Division of Network Medicine at Harvard Medical School. He is one of the founders of network medicine and his current research uncovers how complex networks—from genes to diseases—shape health and human longevity.

HARVARD MEDICAL SCHOOL

Paola Sebastiani is a biostatistician and professor at Boston University whose research focuses on genetic epidemiology and Bayesian modeling to develop prognostic models for understanding complex traits.

JUNTENDO UNIVERSITY

Professor Horie, Chair of Urology, Data Science, and Innovative Longevity Medicine at Juntendo University, is a dual-licensed physician in Japan and the U.S. with specialized training in Urology and Nephrology from the University of Tokyo and UT Southwestern.

THE SCINTILLON RESEARCH INSTITUTE

Alexey received his PhD in molecular immunology from the University of Lausanne (Switzerland) working with Prof. Jean-Pierre Mach. As a postdoctoral fellow with Irv Weissman at Stanford, he discovered common mechanisms between hematopoietic and neural stem cells and developed the Fluorescent Timer protein.

HARVARD MEDICAL SCHOOL

Jessica Lasky-Su, ScD is an Associate Professor in Medicine and Associate Statistician and Epidemiologist at Harvard Medical School and Brigham and Women’s Hospital. Over two decades, Dr. Lasky-Su has focused on the analysis of genetics, genomics, and metabolomics data in large scale human studies, with a primary research focus on lung disease, immune development, and aging.

KING’S COLLEGE LONDON

Dr Chiara Herzog is a junior group leader at King’s College London whose work bridges epigenetics and ageing. She has pioneered research on non-invasive biomarkers from buccal and cervical samples, and co-led large-scale human intervention studies exploring how lifestyle factors impact ageing biomarkers and health. Dr Herzog serves on the Executive Committee of the Biomarkers of Aging consortium, where she works towards consensus for ageing biomarkers.

NATIONAL INSTITUTE OF AGING

Dr. Luigi Ferrucci, a geriatrician and epidemiologist, is Chief of the Longitudinal Studies Section at the NIA and Director of the Baltimore Longitudinal Study on Aging, focusing on the biological pathways of physical and cognitive decline in aging.

UNIVERSITE DE PARIS CITE

With over 1,700 scientific articles, including 72 in CNS journals—Cell (16), Nature (6), Nature Medicine (24), Science (18), and Science Translational Medicine (8), more than 450,000 citations and an h-index of 304, Guido Kroemer is Europe’s most cited biomedical researcher and the most cited worldwide in biology and biochemistry.

INSILICO MEDICINE

Alex Zhavoronkov is the founder, CEO and CBO of Insilico Medicine, a leading clinical-stage biotechnology company developing next-generation generative artificial intelligence and automation platforms for drug discovery. Under his leadership, Insilico raised over $500 million in multiple rounds from expert biotechnology, healthcare, and financial investors, opened R&D centers in 8 countries and regions, and partnered with multiple pharmaceutical, biotechnology, and academic institutions.

BIOAGE LABS

Kristen, co-founder and CEO of BioAge since 2015, is a biotech executive with a PhD in Medical Biophysics and expertise in aging biology, genetics, and bioinformatics, known for her work in building discovery platforms and advising biotech companies.

RETRO BIO

Joe Betts-LaCroix, a scientist turned entrepreneur with roots at Harvard, MIT, and Caltech, is CEO of Retro Biosciences and has founded multiple venture-backed startups, including OQO and Vium, focused on technological and biomedical innovation, with a mission to extend healthy human lifespan.

XPRIZE FOUNDATION

Jamie is the Executive Vice President of the Health Domain at XPRIZE Foundation, and Adjunct Professor in Internal Medicine Section on Gerontology and Geriatric Medicine, and Sticht Center on Healthy Aging and Alzheimer's Prevention at Wake Forest University School of Medicine (WFUSM).

ALTOS LABS

Dr. Steve Horvath, Principal Investigator at Altos Labs, is a leading researcher in biogerontology and epigenetic biomarkers of aging, renowned for developing the first epigenetic clocks and the WGCNA method, with a career spanning UCLA and numerous high-impact scientific contributions.

STANFORD STEM CELL INSTITUTE. STANFORD SCHOOL OF MEDICINE

Dr. Andrea Cipriano is a faculty member at the Stanford Stem Cell Institute and the Department of Obstetrics and Gynecology at Stanford School of Medicine. He also serves on the executive team of the Biomarker of Aging Consortium, where he leads efforts to define, validate, and standardize immune aging biomarkers. His research focuses on the molecular mechanisms of aging and rejuvenation, with particular emphasis on how age-related chromatin changes impair T-cell function and how partial reprogramming can restore immune resilience.

NATURE AGING

Sebastien Thuault is the Chief Editor of Nature Aging, a peer-reviewed scientific journal that publishes research, reviews and opinion articles on aging and age-related diseases covering the life, health and social sciences. Dr Thuault holds a PhD in neuroscience and has been working in scientific publishing and communication for over 10 years. He was formerly an editor at Nature Neuroscience and Nature Communications and launched Nature Aging in 2021.

ALLIANCE FOR LONGEVITY INITIATIVES

Dylan V. Livingston is the Founder and President of the Alliance for Longevity Initiatives, the first 501(c)(4) organization focused on political advocacy for the longevity community. He is also the Founder and Advisor at Friends of Longevity PAC, a Political Action Committee with the goal to help elect pro-longevity politicians to further the legislative agenda of the longevity biotechnology industry and community.